Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | GLA | P06280 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28124853 | 0.89 | CA12 (0.34) | MEN1KMT2A | |
| SCHEMBL3631277 | 0.83 | CYP2C19 (0.34) | CYP2C19MEN1GLAKMT2ACYP1A2 | |
| SCHEMBL28098649 | 0.83 | CYP2C19 (0.34) | CYP2C19MEN1GLAKMT2ACYP1A2 | |
| Methylamine SCHEMBL11311742 | 0.82 | CYP2C19 (0.42) | CYP2C19MEN1GLAKMT2ACYP1A2 | |
| SCHEMBL270457 | 0.82 | CYP2C19 (0.46) | CYP2C19MEN1GLAKMT2ACYP1A2 | |
| SCHEMBL5049085 | 0.80 | OPRM1 (0.37) | — | |
| Ammonia Solution, Strong SCHEMBL7647790 | 0.80 | CYP2C19 (0.44) | CYP2C19MEN1GLAKMT2ACYP1A2 | |
| Diethylamine SCHEMBL7638457 | 0.80 | CYP2C19 (0.44) | CYP2C19MEN1GLAKMT2ACYP1A2 | |
| SCHEMBL27497971 | 0.79 | — | — | |
| SCHEMBL21359747 | 0.78 | CYP2C19 (0.48) | CYP2C19MEN1GLAKMT2ACYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7189417-B2 | Aqueous dispersion of amine-terminated silica particles having a narrowly controlled size range capable of coupling with an agent for diagnostic imaging, drug delivery or gene therapy | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2007-03-13 | — | — | US | claimed |
| US-20240274848-A1 | FLUORINATED IONOMERS, POLYMER ELECTROLYTE MEMBRANES, FUEL CELLS, AND METHODS | COLORADO SCHOOL OF MINES | 2024-08-15 | — | — | US | disclosed |
| WO-2022256669-A1 | FLUORINATED IONOMERS, POLYMER ELECTROLYTE MEMBRANES, FUEL CELLS, AND METHODS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2022-12-08 | — | — | WO | disclosed |
| US-9240287-B2 | Immobilized heteropoly acids and the use of the same electrode stabilization and enhancement | COLORADO SCHOOL OF MINES (US) | 2016-01-19 | — | — | US | disclosed |
| US-8993707-B2 | Aqueous epoxy and organo-substituted branched organopolysiloxane emulsions | WACKER CHEMICAL CORPORATION (US) | 2015-03-31 | — | — | US | disclosed |
| US-20140234750-A1 | IMMOBILIZED HETEROPOLY ACIDS AND THE USE OF THE SAME FOR ELECTRODE STABILIZATION AND ENHANCEMENT | COLORADO SCHOOL OF MINES (US) | 2014-08-21 | — | — | US | disclosed |
| US-20140058012-A1 | Aqueous Epoxy and Organo-Substituted Branched Organopolysiloxane Emulsions | WACKER CHEMICAL CORPORATION (US) | 2014-02-27 | — | — | US | disclosed |
| US-8524131-B2 | Laminate and method for making laminate | NIKE, INC. (US) | 2013-09-03 | — | — | US | disclosed |
| US-20100193992-A1 | LAMINATE AND METHOD FOR MAKING LAMINATE | NIKE, INC. (US) | 2010-08-05 | — | — | US | disclosed |